Literature DB >> 23791549

Malignant epithelioid angiomyolipoma: tumor and metabolic response to everolimus as evaluated with positron emission tomography.

Eliney Faria1, Francesco Turturro, Priya Rao, Surena F Matin.   

Abstract

Entities:  

Keywords:  Angiomyolipoma; Imaging; Kidney tumors; Lymphoma; Mammalian target of rapamycin

Mesh:

Substances:

Year:  2013        PMID: 23791549      PMCID: PMC3834094          DOI: 10.1016/j.clgc.2013.04.032

Source DB:  PubMed          Journal:  Clin Genitourin Cancer        ISSN: 1558-7673            Impact factor:   2.872


× No keyword cloud information.
  27 in total

1.  Sirolimus and temsirolimus for epithelioid angiomyolipoma.

Authors:  Nicholas Wolff; Wareef Kabbani; Thomas Bradley; Ganesh Raj; Lori Watumull; James Brugarolas
Journal:  J Clin Oncol       Date:  2010-01-04       Impact factor: 44.544

2.  Hypoxia-inducible factor determines sensitivity to inhibitors of mTOR in kidney cancer.

Authors:  George V Thomas; Chris Tran; Ingo K Mellinghoff; Derek S Welsbie; Emily Chan; Barbara Fueger; Johannes Czernin; Charles L Sawyers
Journal:  Nat Med       Date:  2005-12-11       Impact factor: 53.440

Review 3.  Translocation carcinomas of the kidney.

Authors:  Pedram Argani; Marc Ladanyi
Journal:  Clin Lab Med       Date:  2005-06       Impact factor: 1.935

4.  18F-FLT PET as a surrogate marker of drug efficacy during mTOR inhibition by everolimus in a preclinical cisplatin-resistant ovarian tumor model.

Authors:  Nicolas Aide; Kathryn Kinross; Carleen Cullinane; Peter Roselt; Kelly Waldeck; Oliver Neels; Donna Dorow; Grant McArthur; Rodney J Hicks
Journal:  J Nucl Med       Date:  2010-09-16       Impact factor: 10.057

5.  Genotype/phenotype correlation in 325 individuals referred for a diagnosis of tuberous sclerosis complex in the United States.

Authors:  Kit Sing Au; Aimee T Williams; E Steve Roach; Lori Batchelor; Steven P Sparagana; Mauricio R Delgado; James W Wheless; James E Baumgartner; Benjamin B Roa; Carolyn M Wilson; Teresa K Smith-Knuppel; Min-Yuen C Cheung; Vicky H Whittemore; Terri M King; Hope Northrup
Journal:  Genet Med       Date:  2007-02       Impact factor: 8.822

6.  Atypical angiomyolipoma of kidney in a patient with tuberous sclerosis: a case report with p53 gene mutation analysis.

Authors:  Linglei Ma; Diane Kowalski; Khurram Javed; Pei Hui
Journal:  Arch Pathol Lab Med       Date:  2005-05       Impact factor: 5.534

7.  Renal epithelioid angiomyolipoma with atypia: a series of 40 cases with emphasis on clinicopathologic prognostic indicators of malignancy.

Authors:  Fadi Brimo; Brian Robinson; Charles Guo; Ming Zhou; Matthieu Latour; Jonathan I Epstein
Journal:  Am J Surg Pathol       Date:  2010-05       Impact factor: 6.394

Review 8.  Role of FDG PET/CT in imaging of renal lesions.

Authors:  R Kochhar; R K Brown; C O Wong; N R Dunnick; K A Frey; P Manoharan
Journal:  J Med Imaging Radiat Oncol       Date:  2010-08       Impact factor: 1.735

9.  Downregulation of 18F-FDG uptake in PET as an early pharmacodynamic effect in treatment of non-small cell lung cancer with the mTOR inhibitor everolimus.

Authors:  Lucia Nogová; Ronald Boellaard; Carsten Kobe; Nikie Hoetjes; Thomas Zander; Stefan Hubert Gross; Sasa Dimitrijevic; Theodore Pellas; Wolfgang Eschner; Katja Schmidt; Christopher Bangard; Wendy Hayes; Roman K Thomas; Markus Dietlein; Giuseppe Giaccone; Otto S Hoekstra; Adriaan A Lammertsma; Jürgen Wolf
Journal:  J Nucl Med       Date:  2009-10-16       Impact factor: 10.057

10.  Activation of the mTOR pathway in sporadic angiomyolipomas and other perivascular epithelioid cell neoplasms.

Authors:  Heidi Kenerson; Andrew L Folpe; Thomas K Takayama; Raymond S Yeung
Journal:  Hum Pathol       Date:  2007-05-22       Impact factor: 3.466

View more
  2 in total

1.  Case report of everolimus-induced sustained partial response in metastatic renal epithelioid angiomyolipoma.

Authors:  Juhi Tayal; Dinesh Chandra Doval; Meenakshi Kamboj; Moushumi Suryavanshi
Journal:  Turk J Urol       Date:  2018-12-19

2.  Metastatic epithelioid angiomyolipoma treated with everolimus in a patient receiving hemodialysis: A case report.

Authors:  Manabu Takai; Koji Kameyama; Shohei Toyota; Shingo Kamei; Shigeaki Yokoi; Satoshi Ishihara; Takashi Deguchi
Journal:  IJU Case Rep       Date:  2019-07-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.